Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

ESMO Congress 2021: Industry Sponsored Satellite Symposia - Non-Metastatic NSCLC and Other Thoracic Malignancies

ESMO Congress 2021 - 1000x250

Friday 17 September

Unmet Needs in Oncogene-Driven NSCLC: How Do We Close the Gap?

08-Unmet-Needs-in-Oncogene-Driven-NSCLC-How-Do-We-Close-the-Gap-NOVARTIS-Thumb

Friday, 10:30 – 12:00
View the satellite invitation

Evolving Treatment Landscape in HNSCC

09-Evolving-Treatment-Landscapes-in-HNSCC-MSD-Thumb

Friday, 18:45 - 20:15
View the satellite invitation

Saturday 18 September

Expert Perspectives in ALK+NSCLC: A Round Table Discussion

13-Expert-Perspectives-in-ALK-NSCLC-A-Round-Table-Discussion-PFIZER-Thumb

Saturday, 08:45 – 09:45
View the satellite invitation

Precision Therapy in NSCLC: The Dawn of KRAS^G12C Inhibition

18-Precision-Therapy-in-NSCLC-The-Dawn-of-KRASG12C-Inhibition-AMGEN-Thumb

Saturday, 10:30 – 12:00
View the satellite invitation

Advances in Antibody Drug Conjugates in Solid Tumors: Current Treatments and Emerging Therapies

21-Advances-in-Antibody-Drug-Conjugates-in-Solid-Tumors-Current-Treatments-and-Emerging-Therapies-DAIICHI-Thumb

Saturday, 18:45 - 20:15
View the satellite invitation

Janssen Satellite Symposium on EGFR-Positive NSCLC

22-Expanding-Horizons-for-the-Targeted-Management-of-EGFR-NSCLC-JANSSEN-Thumb

Saturday, 18:45 – 20:15
View the satellite invitation

Monday 20 September

Emerging Immuno-Oncology Options in Metastatic NSCLC and SCLC: Clinical Evidence and Future Perspectives

43-Evolving-Immuno-Oncology-Options-in-Metastatic-NSCLC-and-SCLC-Current-Evidence-and-Clinical-Perspectives-ASTRAZENECA-Thumb

Monday, 10:30 - 12:00
View the satellite invitation

I-O Revolution: New Perspectives in the Treatment of Thoracic Cancers

46-I-O-Revolution-New-Perspectives-in-the-Treatment-of-Thoracic-Cancers-BMS-Thumb

Monday, 18:45 - 20:15
View the satellite invitation

Optimizing Immuno-Oncology in NSCLC: What Do We Know and Where Should We Go?

47-Optimizing-Immuno-oncology-in-NSCLC-What-Do-We-Know-and-Where-Should-We-Go-SANOFI-Thumb

Monday, 18:45 - 20:15
View the satellite invitation

Tuesday 21 September

Leveraging Antibody-Drug Conjugates in Cancer Care: Evolving Approaches to Bridge Clinical Gaps in Breast, GI, and Lung Tumors

53-Leveraging-Antibody-Drug-Conjugates-in-Cancer-Care-Evolving-Approaches-to-Bridge-Clinical-Gaps-in-Breast-GI-and-Lung-Tumors-PER-Thumb

Tuesday, 10:30 - 12:00
View the satellite invitation

Please note: The European Society for Medical Oncology (ESMO) does not endorse any of the companies, or their products/services, that have sponsored these links.

View the complete ESMO Congress 2021 Industry Sponsored Satellite Symposia Programme